OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2024
(3)
2023
(2)
2022
(2)
2025
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Characterisation of a persistent SARS-CoV-2 infection lasting more than 750 days in a person living with HIV: a genomic analysis.
Not available
S-EPMC12633830
|
biostudies-literature
Cite
Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
Not available
S-EPMC8996632
|
biostudies-literature
Cite
Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
Not available
S-EPMC9278204
|
biostudies-literature
Cite
In-situ formation of one-dimensional coordination polymers in molecular junctions.
Not available
S-EPMC6335403
|
biostudies-literature
Cite
Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report.
Not available
S-EPMC10784163
|
biostudies-literature
Cite
Family wellbeing in general practice: a study protocol for a cluster-randomised trial of the web-based resilience programme on early child development.
Not available
S-EPMC9810520
|
biostudies-literature
Cite
Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose Cisplatin.
Not available
S-EPMC10814481
|
biostudies-literature
Cite
And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept.
Not available
S-EPMC10778176
|
biostudies-literature
Cite
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Not available
S-EPMC9854078
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets